Manufacturer record
Kamla Amrut Pharmaceuticals LLP: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
1 batch manufactured by Kamla Amrut Pharmaceuticals LLP (Gujarat) were declared Not of Standard Quality between May 2026 and May 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
1 record linked to Kamla Amrut Pharmaceuticals LLP in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Compound Sodium Lactate Injection IP 500ml RL | TG5225015Mfg 2025-07 · Exp 2028-06 | BETOther | King Institute of Preventive Medicine & Research, Guindy, Chennai-32State lab | May 2026 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.